CIK 0001831828 · Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812744449
- Phone
- 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-28 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −700 | $37.53 | $26K | 307,972 |
| 2024-08-28 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 842,962 | ||
| 2024-08-21 | Fordyce Marshall PRESIDENT AND CEO | Sale | −14,471 | $39.76 | $575K | 322,667 |
| 2024-08-14 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +15,625 | $2.90 | $45K | 352,763 |
| 2024-08-14 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −15,625 | $37.56 | $587K | 337,138 |
| 2024-08-14 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 858,587 | ||
| 2024-07-01 | JOHNSON DAVID LEE Chief Operating Officer | Grant or award · Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2024-06-07 | Oliger Christy J. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2024-05-16 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Option exercise | +18,151 | $7.87 | $143K | 69,357 |
| 2024-05-16 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Sale | −18,151 | $42.22 | $766K | 51,206 |
| 2024-05-16 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Option exercise | +2,500 | $7.87 | $20K | 53,706 |
| 2024-05-16 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Sale | −2,500 | $43.03 | $108K | 51,206 |
| 2024-05-16 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Option exercise · Stock Option (right to buy) | −20,651 | 69,349 | ||
| 2024-05-15 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Option exercise | +8,221 | $3.94 | $32K | 61,392 |
| 2024-05-15 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Sale | −8,221 | $42.17 | $347K | 53,171 |
| 2024-05-15 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Sale | −1,965 | $42.68 | $84K | 51,206 |
| 2024-05-15 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Option exercise · Stock Option (right to buy) | −8,221 | 58,589 | ||
| 2024-05-15 | SEIDENBERG BETH C Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2024-05-15 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2024-05-15 | MORRISSEY MICHAEL Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 |
Page 13 of 17 · 321 trades